Toll Free: 1-888-928-9744

Illumina, Inc. (ILMN) - Product Pipeline Analysis, 2016 Update

Published: Apr 20, 2016 | Pages: 44 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Illumina, Inc. (Illumina) provides sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company's  portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microarray kits and reagents; molecular biology reagents; and arrays and reagents. It offers human whole-genome sequencing;  microarray services; and instrument services, training and consulting. Illumina caters its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The company's products are distributed to various countries through its distributors in Africa, Asia Pacific, Central America, Europe, the Middle East, North America, and South America. Illumina is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Illumina, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Illumina, Inc. Company Snapshot 6 Illumina, Inc. Company Overview 6 Illumina, Inc. Pipeline Products and Clinical Trials Overview 7 Illumina, Inc. - Pipeline Analysis Overview 9 Business Description 9 Key Facts 10 Illumina, Inc. - Major Products and Services 11 Illumina, Inc. Pipeline Products by Development Stage 13 Illumina, Inc. Pipeline Products Overview 15 Albumin Multiplex Assay 15 Albumin Multiplex Assay Product Overview 15 Carboxyhemoglobin Levels Multiplex Assay 16 Carboxyhemoglobin Levels Multiplex Assay Product Overview 16 Companion Diagnostic Test - Oncology 17 Companion Diagnostic Test - Oncology Product Overview 17 InfiniumDx CytoSNP-12 Assay 18 InfiniumDx CytoSNP-12 Assay Product Overview 18 Lab-On-A-Chip Microfluidic Cartridge 19 Lab-On-A-Chip Microfluidic Cartridge Product Overview 19 LSD-100 Lysosomal Storage Enzyme Analyzer 20 LSD-100 Lysosomal Storage Enzyme Analyzer Product Overview 20 Molecular Diagnostic Test - HIV 21 Molecular Diagnostic Test - HIV Product Overview 21 MRSA Screening Test 22 MRSA Screening Test Product Overview 22 NGS Diagnostic System - Oncology 23 NGS Diagnostic System - Oncology Product Overview 23 NGS Diagnostic System - Reproductive Health 24 NGS Diagnostic System - Reproductive Health Product Overview 24 NGS-Based Companion Diagnostic Test - Metastatic Colorectal Cancer 25 NGS-Based Companion Diagnostic Test - Metastatic Colorectal Cancer Product Overview 25 NGS-based Transplant Diagnostic Assay 26 NGS-based Transplant Diagnostic Assay Product Overview 26 Portable Benchtop Analyzer - Viral Load Assay 27 Portable Benchtop Analyzer - Viral Load Assay Product Overview 27 STAT-Seq Test 28 STAT-Seq Test Product Overview 28 Total Serum Biliruibin Multiplex Assay 29 Total Serum Biliruibin Multiplex Assay Product Overview 29 Unbound Bilirubin Multiplex Assay 30 Unbound Bilirubin Multiplex Assay Product Overview 30 Verifi Prenatal Test 31 Verifi Prenatal Test Product Overview 31 Illumina, Inc. - Key Competitors 32 Illumina, Inc. - Key Employees 33 Illumina, Inc. - Key Employee Biographies 34 Illumina, Inc. - Locations And Subsidiaries 35 Head Office 35 Other Locations & Subsidiaries 35 Recent Developments 38 Illumina, Inc., Recent Developments 38 Apr 05, 2016: Illumina Introduces BaseSpace Informatics Suite to Accelerate Genomic Data Analysis for Sequence Labs 38 Mar 07, 2016: Jay Flatley to Assume Role of Executive Chairman of the Board of Directors of Illumina; Francis deSouza Appointed President and CEO 38 Feb 24, 2016: Illumina Applies CE Mark to VeriSeq NIPT Analysis Software 39 Feb 23, 2016: Illumina Sues Oxford Nanopore for Patent Infringement 39 Feb 02, 2016: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2015 39 Jan 28, 2016: Illumina Appoints Dr. Frances Arnold to Its Board of Directors 41 Jan 11, 2016: Illumina Extends Genomics Portfolio 41 Jan 10, 2016: Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening 42 Jan 07, 2016: Illumina Files Two Patent Infringement Suits in Europe for Infringement of Patents for NIPT 42 Dec 14, 2015: bioMerieux and Illumina announce the launch of bioMerieux EpiSeq, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections 43 Appendix 44 Methodology 44 About GlobalData 44 Contact Us 44 Disclaimer 44
List of Tables
Illumina, Inc. Pipeline Products and Clinical Trials Overview 7 Illumina, Inc. Pipeline Products by Equipment Type 7 Illumina, Inc. Pipeline Products by Indication 8 Illumina, Inc., Key Facts 10 Illumina, Inc., Major Products and Services 11 Illumina, Inc. Number of Pipeline Products by Development Stage 13 Illumina, Inc. Pipeline Products Summary by Development Stage 14 Albumin Multiplex Assay - Product Status 15 Albumin Multiplex Assay - Product Description 15 Carboxyhemoglobin Levels Multiplex Assay - Product Status 16 Carboxyhemoglobin Levels Multiplex Assay - Product Description 16 Companion Diagnostic Test - Oncology - Product Status 17 Companion Diagnostic Test - Oncology - Product Description 17 InfiniumDx CytoSNP-12 Assay - Product Status 18 InfiniumDx CytoSNP-12 Assay - Product Description 18 Lab-On-A-Chip Microfluidic Cartridge - Product Status 19 Lab-On-A-Chip Microfluidic Cartridge - Product Description 19 LSD-100 Lysosomal Storage Enzyme Analyzer - Product Status 20 LSD-100 Lysosomal Storage Enzyme Analyzer - Product Description 20 Molecular Diagnostic Test - HIV - Product Status 21 Molecular Diagnostic Test - HIV - Product Description 21 MRSA Screening Test - Product Status 22 MRSA Screening Test - Product Description 22 NGS Diagnostic System - Oncology - Product Status 23 NGS Diagnostic System - Oncology - Product Description 23 NGS Diagnostic System - Reproductive Health - Product Status 24 NGS Diagnostic System - Reproductive Health - Product Description 24 NGS-Based Companion Diagnostic Test - Metastatic Colorectal Cancer - Product Status 25 NGS-Based Companion Diagnostic Test - Metastatic Colorectal Cancer - Product Description 25 NGS-based Transplant Diagnostic Assay - Product Status 26 NGS-based Transplant Diagnostic Assay - Product Description 26 Portable Benchtop Analyzer - Viral Load Assay - Product Status 27 Portable Benchtop Analyzer - Viral Load Assay - Product Description 27 STAT-Seq Test - Product Status 28 STAT-Seq Test - Product Description 28 Total Serum Biliruibin Multiplex Assay - Product Status 29 Total Serum Biliruibin Multiplex Assay - Product Description 29 Unbound Bilirubin Multiplex Assay - Product Status 30 Unbound Bilirubin Multiplex Assay - Product Description 30 Verifi Prenatal Test - Product Status 31 Verifi Prenatal Test - Product Description 31 Illumina, Inc., Key Employees 33 Illumina, Inc., Key Employee Biographies 34 Illumina, Inc., Other Locations 35 Illumina, Inc., Subsidiaries 36


List of Figures
Illumina, Inc. Pipeline Products by Equipment Type 8 Illumina, Inc. Pipeline Products by Development Stage 13

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing ap

Read More...

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify